Molecular Biology Enzymes, Kits, and Reagents Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Molecular Biology Enzymes, Kits, and Reagents Market: By Product Type (Kits & Reagents, Enzymes, Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases and Other Enzymes), By Application (PCR, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology and Other Applications), By End Users (Academic & Research Institutes, Pharmaceutical & Biotechnology companies, Hospitals & Diagnostic Centers, Other End Users) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Molecular Biology Enzymes, Kits, and Reagents Market size is estimated to be valued at USD 15,675.9 Million in 2021 and is poised to grow at a significant CAGR of 17.5% over 2022-2028. Biological enzymes are important in promoting chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These chemicals are also used in procedures like polymerase chain reaction (PCR), DNA sequencing, and cell analysis. The PCR segment anticipated to grow at significant CAGR over the forecast years owing to the polymerase chain reaction that includes reverse transcriptase–polymerase chain reactions, one of the most used preparative and diagnostic procedures in molecular biology. Moreover, the competitive players are focusing on launching new products and acquisition to maintain the growth in the market. For instance, In February 2021, Thermo Fisher Acquired Mesa Biotech to expand its Life Sciences Solutions business segment. Through this acquisition, the revenue of this segment is expected to increase by approximately USD 200 million in 2021. Increased research and development expenditure, an increase in the number of genome projects, technical advances in the life sciences business, and an increase in the prevalence of genetic diseases. are a few of the elements influencing the industry’s growth throughout the anticipated period.

Key Developments:

In October 2020, New England Biolabs (US) launched the Luna Probe One-Step RT-qPCR 4X Mix with UDG.

Molecular Biology Enzymes, Kits, and Reagents Market

MARKET SUMMARY
-
17.5%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 17.5%
  • Largest Market– North American
  • Fastest Growing Market– Asia-Pacific

Molecular Biology Enzymes, Kits, and Reagents

  • The molecular biology enzymes, kits, and reagents market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The molecular biology enzymes, kits, and reagents market is segmented based on product, application, end users and geography.
Key Players
  • THERMO FISHER SCIENTIFIC INC
  • Illumina, Inc.
  • Qiagen
  • Agilent Technologies, Inc.
  • F. HOFFMANN-LA ROCHE LTD
Molecular Biology Enzymes, Kits, and Reagents

Molecular biology enzymes are utilized in a wide range of applications, including drug discovery and diagnostic testing, R&D, and life science research. Molecular biology products that are routinely used for polymerase chain reaction (PCR) analysis of cell surface markers. This includes qPCR, RT-PCR, and other preparative PCRs that have a therapeutic or diagnostic purpose. The increasing number of R&D activities in biotechnology and drug discovery is a significant growth factor for the global molecular biology enzymes, kits, and reagents market. It is expected to remain such over the projected period of 2022 to 2028.


North America Got Significant Share

Molecular Biology Enzymes, Kits, and Reagents

The Molecular Biology Enzymes, Kits, and Reagents market in North America are likely to hold the highest revenue share in 2021, and the same trend is expected over the forecast period due to the Increased frequency of hereditary and chronic diseases such as cancer, as well as positive government efforts According to the American Cancer Society, around 1,735,350 new cancer cases were identified in the United States in 2018, with roughly 609,640 fatalities. Furthermore, the region's expanding elderly population, as well as increased R&D activities, are likely to boost the market throughout the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Molecular Biology Enzymes, Kits, And Reagents Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The molecular biology enzymes, kits, and reagents market is projected to expand at a CAGR of 17.5% during the forecast period

THERMO FISHER SCIENTIFIC INC, Illumina, Inc., Qiagen, Agilent Technologies, Inc., F. HOFFMANN-LA ROCHE LTD, Merck KGAA, Jena Bioscience GmbH, Bioline Technologies, Promega Corporation, Rockland Immunochemicals

North America is the fastest-growing region for molecular biology enzymes, kits, and reagents market


Report

Table Of Content

1. Executive Summary
2. Global Molecular Biology Enzymes, Kits, and Reagents Market Introduction
2.1. Global Molecular Biology Enzymes, Kits, and Reagents Market – Taxonomy
2.2. Global Molecular Biology Enzymes, Kits, and Reagents Market –Definitions
2.2.1. By Product
2.2.2. By Application
2.2.3. By End users
2.2.4. By Region
3. Global Molecular Biology Enzymes, Kits, and Reagents Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Molecular Biology Enzymes, Kits, and Reagents Market Dynamic Factors – Impact Analysis
3.6. Global Molecular Biology Enzymes, Kits, and Reagents Market – Competition Landscape
4. Global Molecular Biology Enzymes, Kits, and Reagents Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Molecular Biology Enzymes, Kits, and Reagents Market, Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Kits & Reagents
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Enzymes
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Polymerases
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Ligases
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Restriction Endonucleases.
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Reverse Transcriptases
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Other Enzymes
5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
6. Global Molecular Biology Enzymes, Kits, and Reagents Market Forecast, By Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. PCR
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Sequencing
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cloning
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Epigenetics
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Restriction Digestion
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Synthetic Biology
6.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Other Applications
6.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Molecular Biology Enzymes, Kits, and Reagents Market, By End users, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Academic & Research Institutes
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Pharmaceutical & Biotechnology companies
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Hospitals & Diagnostic Centers
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Other End Users
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Molecular Biology Enzymes, Kits, and Reagents Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Molecular Biology Enzymes, Kits, and Reagents Market – Opportunity Analysis Index, Product Type, By Application, End User, and Region, 2022-2028
9. North America Molecular Biology Enzymes, Kits, and Reagents MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Kits & Reagents
9.1.2. Enzymes
9.1.3. Polymerases
9.1.4. Ligases
9.1.5. Restriction Endonucleases
9.1.6. Reverse Transcriptases
9.1.7. Other Enzymes
9.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. PCR
9.2.2. Sequencing
9.2.3. Cloning
9.2.4. Epigenetics
9.2.5. Restriction Digestion
9.2.6. Synthetic Biology
9.2.7. Other Applications
9.3. By End users Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Academic & Research Institutes
9.3.2. Pharmaceutical & Biotechnology companies
9.3.3. Hospitals & Diagnostic Centers
9.3.4. Other End Users
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Molecular Biology Enzymes, Kits, and Reagents Market – Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2022-2028
9.6. North America Molecular Biology Enzymes, Kits, and Reagents Market Dynamics – Trends
10. Europe Molecular Biology Enzymes, Kits, and Reagents Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Kits & Reagents
10.1.2. Enzymes
10.1.3. Polymerases
10.1.4. Ligases
10.1.5. Restriction Endonucleases
10.1.6. Reverse Transcriptases
10.1.7. Other Enzymes
10.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. PCR
10.2.2. Sequencing
10.2.3. Cloning
10.2.4. Epigenetics
10.2.5. Restriction Digestion
10.2.6. Synthetic Biology
10.2.7. Other Applications
10.3. By End users Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Academic & Research Institutes
10.3.2. Pharmaceutical & Biotechnology companies
10.3.3. Hospitals & Diagnostic Centers
10.3.4. Other End Users
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Molecular Biology Enzymes, Kits, and Reagents Market – Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2022-2028
10.6. Europe Molecular Biology Enzymes, Kits, and Reagents Market Dynamics – Trends
11. Asia-Pacific Molecular Biology Enzymes, Kits, and Reagents Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Kits & Reagents
11.1.2. Enzymes
11.1.3. Polymerases
11.1.4. Ligases
11.1.5. Restriction Endonucleases
11.1.6. Reverse Transcriptases
11.1.7. Other Enzymes
11.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. PCR
11.2.2. Sequencing
11.2.3. Cloning
11.2.4. Epigenetics
11.2.5. Restriction Digestion
11.2.6. Synthetic Biology
11.2.7. Other Applications
11.3. By End users Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Academic & Research Institutes
11.3.2. Pharmaceutical & Biotechnology companies
11.3.3. Hospitals & Diagnostic Centers
11.3.4. Other End Users
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Molecular Biology Enzymes, Kits, and Reagents Market – Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2022-2028
11.6. Asia-Pacific Molecular Biology Enzymes, Kits, and Reagents Market Dynamics – Trends
12. Latin America Molecular Biology Enzymes, Kits, and Reagents Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Kits & Reagents
12.1.2. Enzymes
12.1.3. Polymerases
12.1.4. Ligases
12.1.5. Restriction Endonucleases
12.1.6. Reverse Transcriptases
12.1.7. Other Enzymes
12.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. PCR
12.2.2. Sequencing
12.2.3. Cloning
12.2.4. Epigenetics
12.2.5. Restriction Digestion
12.2.6. Synthetic Biology
12.2.7. Other Applications
12.3. By End users Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Academic & Research Institutes
12.3.2. Pharmaceutical & Biotechnology companies
12.3.3. Hospitals & Diagnostic Centers
12.3.4. Other End Users
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Molecular Biology Enzymes, Kits, and Reagents Market – Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2022-2028
12.6. Latin America Molecular Biology Enzymes, Kits, and Reagents Market Dynamics – Trends
13. Middle East and Africa Molecular Biology Enzymes, Kits, and Reagents Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Kits & Reagents
13.1.2. Enzymes
13.1.3. Polymerases
13.1.4. Ligases
13.1.5. Restriction Endonucleases
13.1.6. Reverse Transcriptases
13.1.7. Other Enzymes
13.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. PCR
13.2.2. Sequencing
13.2.3. Cloning
13.2.4. Epigenetics
13.2.5. Restriction Digestion
13.2.6. Synthetic Biology
13.2.7. Other Applications
13.3. By End users Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Academic & Research Institutes
13.3.2. Pharmaceutical & Biotechnology companies
13.3.3. Hospitals & Diagnostic Centers
13.3.4. Other End Users
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Molecular Biology Enzymes, Kits, and Reagents Market – Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2022-2028
13.6. MEA Molecular Biology Enzymes, Kits, and Reagents Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, By Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. THERMO FISHER SCIENTIFIC INC
14.2.2. Illumina, Inc.
14.2.3. Qiagen
14.2.4. Agilent Technologies, Inc.
14.2.5. F. HOFFMANN-LA ROCHE LTD
14.2.6. Merck KGAA
14.2.7. Jena Bioscience GmbH
14.2.8. Bioline Technologies
14.2.9. Promega Corporation
14.2.10. Rockland Immunochemicals.
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • THERMO FISHER SCIENTIFIC INC
  • Illumina, Inc.
  • Qiagen
  • Agilent Technologies, Inc.
  • F. HOFFMANN-LA ROCHE LTD
  • Merck KGAA
  • Jena Bioscience GmbH
  • Bioline Technologies
  • Promega Corporation
  • Rockland Immunochemicals

Description

Molecular Biology Enzymes, Kits, and Reagents Market size is estimated to be valued at USD 15,675.9 Million in 2021 and is poised to grow at a significant CAGR of 17.5% over 2022-2028. Biological enzymes are important in promoting chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These chemicals are also used in procedures like polymerase chain reaction (PCR), DNA sequencing, and cell analysis. The PCR segment anticipated to grow at significant CAGR over the forecast years owing to the polymerase chain reaction that includes reverse transcriptase–polymerase chain reactions, one of the most used preparative and diagnostic procedures in molecular biology. Moreover, the competitive players are focusing on launching new products and acquisition to maintain the growth in the market. For instance, In February 2021, Thermo Fisher Acquired Mesa Biotech to expand its Life Sciences Solutions business segment. Through this acquisition, the revenue of this segment is expected to increase by approximately USD 200 million in 2021. Increased research and development expenditure, an increase in the number of genome projects, technical advances in the life sciences business, and an increase in the prevalence of genetic diseases. are a few of the elements influencing the industry’s growth throughout the anticipated period.

Key Developments:

In October 2020, New England Biolabs (US) launched the Luna Probe One-Step RT-qPCR 4X Mix with UDG.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX